Propanc Biopharma, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q4 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Propanc Biopharma, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q4 2010 to Q1 2024.
  • Propanc Biopharma, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$275.000, a 84% increase year-over-year.
  • Propanc Biopharma, Inc. annual Income Tax Expense (Benefit) for 2024 was -$129K, a 0.55% increase from 2023.
  • Propanc Biopharma, Inc. annual Income Tax Expense (Benefit) for 2023 was -$130K, a 136% decline from 2022.
  • Propanc Biopharma, Inc. annual Income Tax Expense (Benefit) for 2022 was -$55K, a 51.5% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$275 +$1.44K +84% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$129K +$701 +0.54% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-20
Q1 2023 -$1.72K -$1.93K -906% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$129K -$73.9K -133% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-20
Q1 2022 $213 +$112K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$55.5K -$55.5K Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-10
Q1 2021 -$112K -$86K -327% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $0 -$143 -100% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q2 2020 -$135K $340 Apr 1, 2020 Jun 30, 2020 10-K 2021-09-28
Q1 2020 -$26.3K -$27K -3725% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $143 +$117K Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-12
Q3 2019 -$109K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q1 2019 $726 +$1.21K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$117K +$63.3K +35.1% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-14
Q1 2018 -$485 +$306K +99.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$180K -$180K Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q2 2017 -$306K $486 +$1.05K Apr 1, 2017 Jun 30, 2017 10-K 2018-09-17
Q1 2017 -$307K -$306K -$306K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$538 $0 +$72K Oct 1, 2016 Dec 31, 2016 10-Q 2017-02-14
Q3 2016 -$72.5K $0 $0 Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-10
Q2 2016 -$72.5K -$568 -$5.54K -111% Apr 1, 2016 Jun 30, 2016 10-K 2017-09-28
Q1 2016 -$67K $30.00* +$30.00 Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 -$67K -$72K +$10.4K +12.7% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 -$77.5K $0 $0 Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$77.5K $4.97K +$4.79K +2601% Apr 1, 2015 Jun 30, 2015 10-K 2016-09-28
Q1 2015 -$82.3K $0 $0 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$82.3K -$82.4K -$34K -70.2% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-16
Q3 2014 -$48.3K $0 $0 Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$48.3K $184 Apr 1, 2014 Jun 30, 2014 10-K 2015-09-30
Q1 2014 $0 +$30.00 Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$48.5K +$12.7K +20.7% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 $0 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-19
Q1 2013 -$30* Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-20
Q4 2012 -$61.1K +$109K +64.2% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q4 2011 -$170K -$89.7K -111% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-20
Q4 2010 -$80.8K Oct 1, 2010 Dec 31, 2010 10-Q/A 2012-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.